4.6 Article

Targeting a Lipid Desaturation Enzyme, SCD1, Selectively Eliminates Colon Cancer Stem Cells through the Suppression of Wnt and NOTCH Signaling

Journal

CELLS
Volume 10, Issue 1, Pages -

Publisher

MDPI
DOI: 10.3390/cells10010106

Keywords

CSC; SCD1; monounsaturated fatty acid; NOTCH; Wnt

Categories

Funding

  1. Korean government [NRF-2018R1D1A1B07045153, NRF-2020R1A2C1006091]

Ask authors/readers for more resources

The study suggests that targeting stearoyl-CoA desaturase 1 (SCD1) may selectively eliminate cancer stem cells (CSCs) in colon cancer by inducing apoptosis and affecting the survival ability of CSCs through specific signaling pathways. The suppression effect of SCD1 inhibition on CSCs is primarily mediated by the downregulation of Notch and Wnt signaling genes, indicating the potential of targeting SCD1 in clinical settings for colon cancer treatment.
The elimination of the cancer stem cell (CSC) population may be required to achieve better outcomes of cancer therapy. We evaluated stearoyl-CoA desaturase 1 (SCD1) as a novel target for CSC-selective elimination in colon cancer. CSCs expressed more SCD1 than bulk cultured cells (BCCs), and blocking SCD1 expression or function revealed an essential role for SCD1 in the survival of CSCs, but not BCCs. The CSC potential selectively decreased after treatment with the SCD1 inhibitor in vitro and in vivo. The CSC-selective suppression was mediated through the induction of apoptosis. The mechanism leading to selective CSC death was investigated by performing a quantitative RT-PCR analysis of 14 CSC-specific signaling and marker genes after 24 and 48 h of treatment with two concentrations of an inhibitor. The decrease in the expression of Notch1 and AXIN2 preceded changes in the expression of all other genes, at 24 h of treatment in a dose-dependent manner, followed by the downregulation of most Wnt- and NOTCH-signaling genes. Collectively, we showed that not only Wnt but also NOTCH signaling is a primary target of suppression by SCD1 inhibition in CSCs, suggesting the possibility of targeting SCD1 against colon cancer in clinical settings.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available